DoxorubicinAntibiotics, AntineoplasticInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsTaxoidsDrug Resistance, NeoplasmAntineoplastic AgentsCisplatinCell Line, TumorCombined Modality TherapyChemotherapy, AdjuvantRemission InductionTreatment OutcomeApoptosisPaclitaxelBreast NeoplasmsCaspase 12Disease-Free SurvivalTumor Suppressor Protein p53CyclophosphamideSurvival AnalysisDrug Administration ScheduleNeoadjuvant TherapyNeoplasm StagingEtoposideSurvival RateLung NeoplasmsAntineoplastic Agents, PhytogenicHead and Neck NeoplasmsFluorouracilVincristineDrug ResistanceCarcinoma, Squamous CellCardiomyopathiesDaunorubicinCytarabineCarboplatinMitochondria, HeartVinblastineDNA DamagePrognosisIfosfamideCarcinoma, Non-Small-Cell LungLeukemia, Myeloid, AcuteSignal TransductionDeoxycytidineRNA, MessengerDose-Response Relationship, DrugNeoplasm MetastasisRNA, Small InterferingGene Expression Regulation, NeoplasticTumor Markers, BiologicalMyocardiumHeartTime FactorsNeoplasm Recurrence, LocalDrug Resistance, MultipleDrug Resistance, MicrobialNeutropeniaMethotrexateAdenocarcinomaRadiotherapy, AdjuvantDrug Resistance, BacterialBleomycinEnzyme InductionP-GlycoproteinMitoxantroneTumor BurdenPrecursor Cell Lymphoblastic Leukemia-LymphomaChemoradiotherapyFollow-Up StudiesKaplan-Meier EstimateNeoplasmsRadiotherapyInfusions, IntravenousGranulocyte Colony-Stimulating FactorIdarubicinRadiotherapy DosageSalvage TherapyTumor Necrosis Factor-alphaBone NeoplasmsAnthracyclinesHypopharyngeal NeoplasmsAntimetabolites, AntineoplasticDisease ProgressionLaryngectomyProspective StudiesLeukopeniaLeukemia, MyeloidTransplantation, AutologousNasopharyngeal NeoplasmsBrain NeoplasmsPrednisoneOvarian NeoplasmsEpirubicinAntibodies, MonoclonalTesticular NeoplasmsMelphalanXenograft Model Antitumor AssaysBridged Compounds